Blue Jet Healthcare Past Earnings Performance
Past criteria checks 2/6
Blue Jet Healthcare has been growing earnings at an average annual rate of 3.7%, while the Pharmaceuticals industry saw earnings growing at 16.8% annually. Revenues have been declining at an average rate of 8.1% per year. Blue Jet Healthcare's return on equity is 18.6%, and it has net margins of 22.6%.
Key information
3.7%
Earnings growth rate
3.7%
EPS growth rate
| Pharmaceuticals Industry Growth | 17.5% |
| Revenue growth rate | -8.1% |
| Return on equity | 18.6% |
| Net Margin | 22.6% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue Miss: Blue Jet Healthcare Limited Fell 13% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Aug 10
Blue Jet Healthcare Limited's (NSE:BLUEJET) Price In Tune With Earnings
Jul 26Blue Jet Healthcare's (NSE:BLUEJET) Solid Earnings May Rest On Weak Foundations
Jun 02Blue Jet Healthcare Limited Just Missed Earnings - But Analysts Have Updated Their Models
May 30Revenue & Expenses Breakdown
How Blue Jet Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 6,950 | 1,574 | 552 | 0 |
| 31 Mar 24 | 7,116 | 1,638 | 532 | 0 |
| 31 Dec 23 | 7,449 | 1,748 | 503 | 0 |
| 30 Sep 23 | 7,471 | 1,802 | 484 | 0 |
| 30 Jun 23 | 7,560 | 1,763 | 454 | 0 |
| 31 Mar 23 | 7,210 | 1,600 | 419 | 0 |
| 31 Mar 22 | 6,835 | 1,816 | 330 | 0 |
| 31 Mar 21 | 4,989 | 1,384 | 290 | 0 |
| 31 Mar 20 | 5,382 | 1,448 | 239 | 0 |
Quality Earnings: BLUEJET has high quality earnings.
Growing Profit Margin: BLUEJET's current net profit margins (22.6%) are lower than last year (23.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BLUEJET's earnings have grown by 3.7% per year over the past 5 years.
Accelerating Growth: BLUEJET's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: BLUEJET had negative earnings growth (-10.7%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (19.1%).
Return on Equity
High ROE: BLUEJET's Return on Equity (18.6%) is considered low.